Work record / Capital / Medical device US entry / Questions answered
Medical device US entry: questions answered
What people ask me about Medical device US entry, and my answers. The project itself has its own page.
How did the exclusivity finding reshape the channel plan?
The workable piece was introductions to particular buyers, with no full market launch. A US entry costs real money. It needs new compliance, a new corporate structure and fresh contracts, and the investor-readiness work has to come before any introduction. A commission-only arrangement cannot cover that, so we never committed full resources to a launch. We still shop it around, and it lives on the back burner. If a genuine buyer turns up, an assisted living operator for example, we would go after that deal, and with a buyer at the table we would revisit the terms.